Faisal Zain is a seasoned visionary in the medical technology and pharmaceutical sectors, recognized for his ability to dismantle the traditional boundaries between manufacturing, diagnostics, and commercial strategy. With 2026 ushering in a new era of agentic AI, he has become a leading voice in
Forensic toxicologists have officially identified mitragynine as one of the top five substances involved in overdose deaths in Oklahoma, alongside fentanyl and methamphetamine. This stark finding served as the catalyst for a comprehensive interim study initiated by the Oklahoma House Alcohol,
Recent freedom of information requests have revealed that the Ontario Ministry of Health spent $13.3 million on advertising during the most recent fiscal year alone. The intersection of health policy and fiscal transparency has reached a critical juncture in Ontario, as new documents stir debate
Data suggests that doctors who receive frequent payments from drug manufacturers are significantly more likely to prescribe higher and potentially dangerous doses of medications. This unsettling reality forms the core of a modern healthcare dilemma where clinical necessity competes with aggressive
UnitedHealthcare faces demands to turn over profits earned from patients who may have enrolled based on inaccurate information regarding Fairview’s network status. This federal lawsuit, initiated by Fairview Health Services, a prominent health system headquartered in Minneapolis, marks a s
The digital health landscape is currently undergoing a profound transformation as traditional medical barriers dissolve under the weight of high-production media campaigns. The success of modern telehealth marketing depends on its ability to balance the efficiency of digital tools with the
